Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 506 entries
View as:

Safety and Efficacy of Punctal Plug Insertion in Patients With Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT01684436 Org: User:
Start: 10/01/12 End: 07/31/13 Due: 07/31/14

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01253902 Org: User:
Start: 12/31/10 End: 10/31/11 Due: 10/31/12

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial

Phase: N/A Priority: Normal
NCT ID: NCT01178827 Org: User:
Start: 08/31/10 End: 03/31/11 Due: 03/31/12

A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02003534 Org: User:
Start: 07/31/10 End: 02/28/13 Due: 02/28/14

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00799227 Org: User:
Start: 01/01/09 End: 12/01/09 Due: 12/01/10

A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Phase: N/A Priority: Normal
NCT ID: NCT01632423 Org: User:
Start: 02/28/10 End: 11/30/10 Due: 11/30/11

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04320745 Org: User:
Start: 05/19/20 End: 06/24/21 Due: 06/24/22

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Phase: N/A Priority: Normal
NCT ID: NCT02455050 Org: User:
Start: 12/31/14 End: 08/31/15 Due: 08/31/16

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02010788 Org: User:
Start: 02/28/14 End: 07/31/16 Due: 07/31/17

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Phase: N/A Priority: Normal
NCT ID: NCT03285308 Org: User:
Start: 09/29/17 End: 07/08/20 Due: 07/08/21

Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow

Phase: N/A Priority: Normal
NCT ID: NCT00811850 Org: User:
Start: 12/31/08 End: 12/31/09 Due: 12/31/10

Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

Phase: N/A Priority: Normal
NCT ID: NCT03559972 Org: User:
Start: 06/04/18 End: 12/03/18 Due: 12/03/19

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

Phase: N/A Priority: Normal
NCT ID: NCT01853085 Org: User:
Start: 04/01/13 End: 03/01/14 Due: 03/01/15

A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01633788 Org: User:
Start: 08/22/12 End: 02/05/15 Due: 02/05/16

12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03777059 Org: User:
Start: 12/14/18 End: 06/19/20 Due: 06/19/21

JUVÉDERM VOLUX® for Chin Retrusion in China

Phase: N/A Priority: Normal
NCT ID: NCT04559984 Org: User:
Start: 10/15/20 End: 08/26/22 Due: 08/26/23

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT01662492 Org: User:
Start: 10/31/12 End: 08/31/16 Due: 08/31/17

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01797081 Org: User:
Start: 01/31/13 End: 07/07/14 Due: 07/07/15

Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01199965 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants

Phase: N/A Priority: Normal
NCT ID: NCT01785069 Org: User:
Start: 12/10/12 End: 11/30/15 Due: 11/30/16

A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01879683 Org: User:
Start: 07/31/13 End: 06/30/14 Due: 06/30/15

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00651859 Org: User:
Start: 11/30/02 End: 01/31/04 Due: 01/31/05

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00835198 Org: User:
Start: 12/31/08 End: 08/31/09 Due: 08/31/10

A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02155543 Org: User:
Start: 05/31/14 End: 01/31/15 Due: 01/31/16

Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Phase: N/A Priority: Normal
NCT ID: NCT02951975 Org: User:
Start: 01/25/17 End: 12/19/18 Due: 12/19/19